In silico comparison of gene expression levels in ten human tumor types reveals candidate genes associated with carcinogenesis

被引:10
作者
Chen, S
Zhu, B
Yu, L
机构
[1] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China
[2] Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China
关键词
D O I
10.1159/000087513
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Most human cancers are characterized by genomic instability. Changes associated with such may result in altered expression of numerous genes. The sequence information available in the public databases can be used to identify transcripts differentially expressed in cancers. Determining cancer-related genes that are commonly deregulated in different tumor types may facilitate identification of targets for cancer diagnoses and therapeutic treatments. Using a data-mining tool named Digital Differential Display (DDD) from the Uni-Gene database at the NCBI web site, gene expression levels of ten different tumor types and their counterpart normal tissues were analyzed. Unigenes which showed transcriptional regulation in more than five tumor types with 62-fold differences from normal tissues were identified. The expression data of selected Unigenes were subjected to clustering analysis. 127 commonly up-regulated genes and 92 commonly down-regulated genes were identified. Clustering analysis using these genes showed that most tumor types can be clustered into a separate branch from most normal tissues. Nineteen genes that have been shown to be involved in carcinogenesis by experimental evidence were also identified. Present computational analyses revealed 219 candidate cancer-related genes that are commonly deregulated in ten human tumor types which may contribute to the progress of carcinogenesis. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 25 条
[1]   Integrin (α6β4) regulation of eIF-4E activity and VEGF translation:: a survival mechanism for carcinoma cells [J].
Chung, J ;
Bachelder, RE ;
Lipscomb, EA ;
Shaw, LM ;
Mercurio, AM .
JOURNAL OF CELL BIOLOGY, 2002, 158 (01) :165-174
[2]   Pigment epithelium-derived factor: A potent inhibitor of angiogenesis [J].
Dawson, DW ;
Volpert, OV ;
Gillis, P ;
Crawford, SE ;
Xu, HJ ;
Benedict, W ;
Bouck, NP .
SCIENCE, 1999, 285 (5425) :245-248
[3]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[4]  
Ito Y, 2002, INT J MOL MED, V9, P373
[5]   Apoptosis: A link between cancer genetics and chemotherapy [J].
Johnstone, RW ;
Ruefli, AA ;
Lowe, SW .
CELL, 2002, 108 (02) :153-164
[6]   Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors [J].
Kikuchi, T ;
Toyota, M ;
Itoh, F ;
Suzuki, H ;
Obata, T ;
Yamamoto, H ;
Kakiuchi, H ;
Kusano, M ;
Issa, JPJ ;
Tokino, T ;
Imai, K .
ONCOGENE, 2002, 21 (17) :2741-2749
[7]   In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells [J].
Leerkes, MR ;
Caballero, OL ;
Mackay, A ;
Torloni, H ;
O'Hare, MJ ;
Simpson, AJG ;
de Souza, SJ .
GENOMICS, 2002, 79 (02) :257-265
[8]   In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies [J].
Mahtabifard, A ;
Merritt, RE ;
Yamada, RE ;
Crystal, RG ;
Korst, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (01) :28-38
[9]   Cell adhesion molecules and adhesion abnormalities in prostate cancer [J].
Mason, MD ;
Davies, G ;
Jiang, WG .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 41 (01) :11-28
[10]   P57(KIP2), A STRUCTURALLY DISTINCT MEMBER OF THE P21(CIP1) CDK INHIBITOR FAMILY, IS A CANDIDATE TUMOR-SUPPRESSOR GENE [J].
MATSUOKA, S ;
EDWARDS, MC ;
BAI, C ;
PARKER, S ;
ZHANG, PM ;
BALDINI, A ;
HARPER, JW ;
ELLEDGE, SJ .
GENES & DEVELOPMENT, 1995, 9 (06) :650-662